Marinus Pharmaceuticals (MRNS) PT Lowered to $22 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst Jason N. Butler lowered the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $22.00 (from $23.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
